Showing 231-240 of 2319 results for "".
Adapting Dermatology for the Digital Patient
https://practicaldermatology.com/topics/practice-management/adapting-dermatology-for-the-digital-patient/23630/A dermatologist with expertise in technology for health care provides an overview of the field and shares her success story.Helping Patients Look Like Their Best Personal Self
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/shamban/18973/Has someone come into your office asking to look radically different? That's a big red flag warning for Ava Shamban, MD, owner and director of two dermatological practices in Santa Monica and Beverly Hills, Calif., frequent TV commentator, and author of the book, “Heal Your Skin: The Breakthrough PlBotox Cosmetic Patient Perceptions
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/botox-cosmetic-patient-perceptions/19382/Results of a survey by Allergan and Healthy Women reveal changing perceptions about treatment with the neurotoxin. Featuring Courtney Thorne-Smith.AI for Patient Education and More
https://practicaldermatology.com/series/c-suite-chats/ai-for-patient-education-and-more/36239/Anastasia Georgievskaya, founder of Haut.AI, discusses the impact of new artificial intelligence tools such as a virtual skincare try-on that shows customers how sunscreen and its ingredients will impact skin over time.Maui Derm Panel: GLP-1 Agonists Can Help Psoriasis Patients
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/maui-derm-panel-glp-1-agonists-can-help-psoriasis-patients/32917/Only 11% of Maui Derm 2025 audience members polled said they were comfortable prescribing weight-loss drugs, and 49% said they were not at all—but they should be, according to the presenters of “Psoriasis Update 2025” at the conference in Maui, Hawaii.Topical Rejuvenation Options for the Hyperpigmentation Patient
https://practicaldermatology.com/topics/general-topics/PD0609_03-php/22812/Appropriate rejuvenation regimens can actually correct hyperpigmentation and not make it worse.Fighting for Coverage: Combatting private insurance to get patients on the drugs they need
https://practicaldermatology.com/issues/july-2025/fighting-for-coverage/36503/Aside from decreasing reimbursement rates, obtaining prior authorization from private insurance for medications that our patients desperately need to improve their lives, improve their skin conditions, and improve their wellbeing is probably the greatest challenge that dermatologists face today.Hydroquinone in 2021
https://practicaldermatology.com/topics/pigmentary-disorders/hydroquinone-in-2021/23592/A year after OTC hydroquinone was pulled from the market as part of the CARES Act, a dermatologist discusses the effects on patient care.Rosacea Unveiled: A YoungMD Connect Open Discussion with Dr. Corey Hartman
https://practicaldermatology.com/youngmd-connect/wrap-ups/rosacea-unveiled-a-youngmd-connect-open-discussion-with-dr-corey-hartman/27168/In his YoungMD Connect virtual session on the topic of rosacea, Dr. Corey Hartman shared extensive experience with the eager viewing audience. Topics discussed included treating patients with rosacea, including those with skin of color, as well as clinical pearls on diagnosing and managing this commNIH Analysis Examines Association Between AD and Comorbidities
https://practicaldermatology.com/programs/practical-dermatology-atopic-dermatitis/nih-analysis-examines-association-between-ad-and-comorbidities/27113/In this week's DermwireTV, new NIH data looks at the association between AD and several health conditions; a study evaluates the effect of lebrikizumab monotherapy in patients with moderate-to-severe AD over 16 weeks; and Andrew Mastro provides tips on how to optimize the first 5 minutes with a pati